Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
I CAN PhIII interim analysis met primary endpoint
Regulatory Filings Classification · 1% confidence The document is an RNS announcement from AstraZeneca PLC reporting positive interim Phase III clinical trial results for Ultomiris. It is not an earnings report, financial supplement, or formal regulatory form (e.g., 10-K, IR, ER). It is a press release via the London Stock Exchange’s Regulatory News Service (RNS), which falls under the general regulatory announcements/fallback category.
2026-04-21 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-20 English
Third tozorakimab positive Phase III in COPD
Regulatory Filings Classification · 1% confidence The document is an RNS press release announcing AstraZeneca’s positive Phase III MIRANDA trial results for tozorakimab in COPD. It is not a financial report (10-K, IR), earnings release, management discussion, board change, or capital transaction. It is a general regulatory announcement distributed via the London Stock Exchange’s RNS service, fitting the fallback category of Regulatory Filings (RNS).
2026-04-20 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-09 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an RNS announcement dated 9 April 2026 detailing the poll voting results for each resolution proposed at AstraZeneca’s Annual General Meeting, including votes for, against, total votes cast, and percentages. It specifically reports the results of shareholder voting, which corresponds to a Declaration of Voting Results & Voting Rights Announcement.
2026-04-09 English
Special Business Approved at AGM
AGM Information Classification · 1% confidence The document is the formal resolutions passed at the company’s Annual General Meeting, detailing ordinary and special resolutions adopted on 9 April 2026. It is not a financial report, earnings release, or proxy request but is AGM-specific material. This aligns with the “AGM Information” category (AGM-R).
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.